Animal health company Elanco has announced its completion of the acquisition of AHV International, a Dutch innovator in farm animal health.

Elanco has said that the acquisition will allow the company to offer more proactive nutritional health interventions that can be tailored to the individual health of each cow to meet their health and disease prevention needs when they’re most susceptible.

For example, AHV's StopLac is a product designed to reduce milk production in dairy cows during the dry-off process at the end of a lactation cycle.

ADVERTISEMENT

Additionally, AHV’s quorum-sensing technology is based on plant-derived extracts that disrupt biofilm formation exposing pathogens to the animal’s natural immune system.

This product allows the animal’s own immune system to better fight disease, reducing the need for antibiotics.

Innovations

Elanco is aiming to enhance global accessibility through these innovations.

“The AHV addition is a strategic fit for Elanco by providing innovative tools for producers and veterinarians to improve the well-being of dairy cows,” Dr Ramiro M Cabral executive vice president of Elanco said of the acquisition.

“AHV's portfolio meaningfully expands our solutions for sustainability, animal welfare and transition cow health, as well as for retail packaged goods.

“Together, with our dedicated scientific and technical Elanco team, the integration will unite the strengths of both organisations to deliver a comprehensive solution portfolio for our customers.”